UNSPSC 51162706: Carbocisteine

This classification denotes a mucolytic agent with the molecular formula C5H9NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 740J2QX53R, chemically known as (rs)-cysteine, s-(carboxymethyl)- but more generally known as carbocisteine, which bears US NIH Compound Identifier 1080. European Medicines Agency schedules Carbocisteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11790MIG.

World Health Organization schedules carbocisteine in its Anatomical Therapeutic Chemical (ATC) Classification. CARBOCISTEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule carbocisteine under HS 29309016 and SITC 51549. SMILES: SCC(N)C(=O)O.

UNSPSC 51162706 Carbocisteine, a Commodity code, covers pharmaceutical products and related services that state and local governments procure for healthcare delivery to incarcerated individuals, patients in correctional settings, and community health programs. Recent solicitations show state and local buyers acquiring parenteral nutrition solutions, intravenous products, controlled substances for medical use, naloxone, and drug deactivation systems through competitive bidding. The Washington State Department of Corrections and Seminole County, Florida represent the issuing-body mix, which includes state corrections agencies and county health departments. Scope of work centers on pharmaceutical supply and delivery services with rapid turnaround requirements — parenteral nutrition bags delivered within 24 hours of order, other IV solutions within 8 hours — and vendor qualifications demanding documented experience in preparing and delivering specialized pharmaceutical products, maintaining patient lab monitoring, and adjusting formulations as medically required.

The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, soliciting parenteral products and services for eight correctional facilities across three regions (West, Central, and East Washington), with a response deadline of October 7, 2026 and a pre-bid conference scheduled for September 23, 2026. The contract encourages participation from certified small businesses (25% aspirational), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with DOC anticipating selection of up to three contractors per region and contract terms running November 26, 2026 through June 30, 2030. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023. Recent activity spans Washington state and Florida, with both solicitations requiring vendors to maintain specified insurance coverages, comply with state business licensing requirements, and pass background clearances or E-Verify employment authorization checks.